Agios Pharmaceuticals, Inc. (AGIO)
27.47
-0.21
(-0.76%)
USD |
NASDAQ |
Mar 06, 16:00
27.48
+0.01
(+0.04%)
After-Hours: 20:00
Agios Pharmaceuticals SG&A Expense (TTM) : 180.28M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 8.398B |
| CorMedix, Inc. | 60.19M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |
| Enanta Pharmaceuticals, Inc. | 40.10M |
| Karyopharm Therapeutics, Inc. | 105.21M |